Cargando…

Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic

Despite evidence for the effectiveness of cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD), many individuals with OCD lack access to needed behavioral health treatment. Although some literature suggests that virtual modes of treatment for OCD are effective, it remains uncle...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinciotti, Caitlin M., Bulkes, Nyssa Z., Horvath, Gregor, Riemann, Bradley C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692880/
https://www.ncbi.nlm.nih.gov/pubmed/34956827
http://dx.doi.org/10.1016/j.jocrd.2021.100705
_version_ 1784619025929601024
author Pinciotti, Caitlin M.
Bulkes, Nyssa Z.
Horvath, Gregor
Riemann, Bradley C.
author_facet Pinciotti, Caitlin M.
Bulkes, Nyssa Z.
Horvath, Gregor
Riemann, Bradley C.
author_sort Pinciotti, Caitlin M.
collection PubMed
description Despite evidence for the effectiveness of cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD), many individuals with OCD lack access to needed behavioral health treatment. Although some literature suggests that virtual modes of treatment for OCD are effective, it remains unclear whether intensive programs like partial hospitalization and intensive outpatient programs (PHP and IOPs) can be delivered effectively over telehealth (TH) and within the context of a global pandemic. Limited extant research suggests that clinicians perceive attenuated treatment response during the pandemic. The trajectory and outcomes of two matched samples were compared using linear mixed modeling: a pre-COVID in-person (IP) sample (n = 239) and COVID TH sample (n = 239). Findings suggested that both modalities are effective at treating OCD and depressive symptoms, although the pandemic TH group required an additional 2.6 treatment days. The current study provides evidence that PHP and IOP treatment delivered via TH during the COVID-19 pandemic is approximately as effective as pre-pandemic IP treatment and provides promising findings for the future that individuals with complicated OCD who do not have access to IP treatment can still experience significant improvement in symptoms through TH PHP and IOP treatment during and potentially after the pandemic.
format Online
Article
Text
id pubmed-8692880
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-86928802021-12-22 Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic Pinciotti, Caitlin M. Bulkes, Nyssa Z. Horvath, Gregor Riemann, Bradley C. J Obsessive Compuls Relat Disord Article Despite evidence for the effectiveness of cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD), many individuals with OCD lack access to needed behavioral health treatment. Although some literature suggests that virtual modes of treatment for OCD are effective, it remains unclear whether intensive programs like partial hospitalization and intensive outpatient programs (PHP and IOPs) can be delivered effectively over telehealth (TH) and within the context of a global pandemic. Limited extant research suggests that clinicians perceive attenuated treatment response during the pandemic. The trajectory and outcomes of two matched samples were compared using linear mixed modeling: a pre-COVID in-person (IP) sample (n = 239) and COVID TH sample (n = 239). Findings suggested that both modalities are effective at treating OCD and depressive symptoms, although the pandemic TH group required an additional 2.6 treatment days. The current study provides evidence that PHP and IOP treatment delivered via TH during the COVID-19 pandemic is approximately as effective as pre-pandemic IP treatment and provides promising findings for the future that individuals with complicated OCD who do not have access to IP treatment can still experience significant improvement in symptoms through TH PHP and IOP treatment during and potentially after the pandemic. Elsevier Inc. 2022-01 2021-12-16 /pmc/articles/PMC8692880/ /pubmed/34956827 http://dx.doi.org/10.1016/j.jocrd.2021.100705 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pinciotti, Caitlin M.
Bulkes, Nyssa Z.
Horvath, Gregor
Riemann, Bradley C.
Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic
title Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic
title_full Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic
title_fullStr Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic
title_full_unstemmed Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic
title_short Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic
title_sort efficacy of intensive cbt telehealth for obsessive-compulsive disorder during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692880/
https://www.ncbi.nlm.nih.gov/pubmed/34956827
http://dx.doi.org/10.1016/j.jocrd.2021.100705
work_keys_str_mv AT pinciotticaitlinm efficacyofintensivecbttelehealthforobsessivecompulsivedisorderduringthecovid19pandemic
AT bulkesnyssaz efficacyofintensivecbttelehealthforobsessivecompulsivedisorderduringthecovid19pandemic
AT horvathgregor efficacyofintensivecbttelehealthforobsessivecompulsivedisorderduringthecovid19pandemic
AT riemannbradleyc efficacyofintensivecbttelehealthforobsessivecompulsivedisorderduringthecovid19pandemic